Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo. by Hulley, P, Hartikka, J, Abdel'Al, S, Engels, P, Buerki, H, Wiederhold, K, Müller, T, Kelly, P, Lowe, D, Lübbert, H

The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects. by Wiessner, C, Wiederhold, K, Tissot, A, Frey, P, Danner, S, Jacobson, L, Jennings, G, Lüönd, R, Ortmann, R, Reichwald, J, Zurini, M, Mir, A, Bachmann, M, Staufenbiel, M

Architecture of eukaryotic mRNA 3'-end processing machinery by Casañal, A, Kumar, A, Hill, C, Easter, A, Emsley, P, Degliesposti, G, Gordiyenko, Y, Santhanam, B, Wolf, J, Wiederhold, K, Dornan, G, Skehel, M, Robinson, C, Passmore, L